With a multifaceted background spanning molecular biology, immunology, and oncology, I am a dedicated researcher committed to unraveling the intricate molecular pathways underlying disease progression while identifying promising therapeutic targets. Currently serving as a Post-Doctoral Fellow at University of California San Francisco my work focuses on elucidating the role of components within the Integrated Stress Response in hepatic carcinoma, with the ultimate aim of identifying novel treatment targets. Simultaneously, I explore biomarkers for Hepatocellular Carcinoma (HCC) treatment, particularly in conjunction with anti-PDL1 therapy, and assess the potential of Cabozantinib and Lenvatinib as Tyrosine kinase inhibitors. Prior to this, my tenure at the Indian Institute of Technology Bombay and University of Washington, Seattle saw me characterizing polymorphisms in Plasmodium falciparum's histidine-rich protein, leveraging antibody characterization techniques to enhance malaria rapid diagnostic kits. My doctoral research at P. D Hinduja National Hospital delved into the influence of gastric microbial communities on Helicobacter pylori infections, further exploring protein chip arrays for screening enteropathogenic Escherichia coli. This diverse portfolio equips me with a comprehensive skill set in molecular techniques, data analysis, and project management, enabling me to contribute significantly to interdisciplinary research endeavors aimed at translating basic discoveries into clinically impactful applications, ultimately enhancing patient care and outcomes.

Bag S, Saha B, Mehta O, Anbumani D, Kumar N, Dayal M, Verima P, et al. An Improved Method for High Quality Metagenomics DNA Extraction from Human and Environmental Samples. Sci Rep. Nature Publishing Group; 2016;6(4):26775. Available from: http://www.nature.com/articles/srep26775

ï�¬ Das A, Pereira V, Saxena S, Shankar Ghosh T, Anbumani D, Bag S, et al. Gastric microbiome of Indian patients with Helicobacter pylori infection, and their interaction networks. Sci Rep. Springer US; 2017;7(15438):1–9. Available from: https://www.nature.com/articles/s41598-017-15510-6 Sci Rep (Nature) recognized as the top 100 read articles in 2017 under the section of microbiology.

ï�¬ Pereira V, Abraham P, Nallapeta S, Shetty A. Gastric bacterial Flora in patients Harboring Helicobacter pylori with or without chronic dyspepsia: analysis by matrix-assisted laser desorption ionization time-of-flight mass spectroscopy. BMC Gastroenterol. BMC Gastroenterology; 2018; 18:1–8. https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-018-0744-8

� Abraham P, Pereira V. Response to Treatment of Helicobacter pylori-associated Dyspepsia: Eradication of Helicobacterpylori or Correction of Gastric or Intestinal Dysbiosis? Journal of Neurogastroenterology and Motility. 2018;24(3):502. doi:10.5056/jnm18091 Available from: https://europepmc.org/article/MED/29969862

� Majumder R, Barrios L, Pereira V (2021) Hypoxia and Interleukin-6 Exacerbate Blood Coagulation in COVID-19 Patients. J Lung Vol.2 No. 4: 6 � V Pereira, Exploring the Parallels and Divergence of Liver Regeneration and DEI: Unveiling the Complexities of Healing and Equity (2023), Acta Scientific 6 (Issue 8), 18-19

� Tina Nguyen, Devin Melancon, Verima Pereira, Jarrod Harman, Sabyasachi Chatterjee, Arnold H. Zea, Samarpan Majumder, Rinku Majumder. Downregulation of Protein S in Patients with Severe COVID-19 Augments the Prothrombotic State (in print).

� V Pereira, Liver Cancer: The Cosmic Abyss Within Your Body(2024), Acta Scientific 7 (Issue 2), 2582-19.https://actascientific.com/ASGIS-7-2.ph